Literature DB >> 29860711

Sleep evaluation by questionnaires and actigraphy in patients with cancer.

Tomoyuki Kawada1.   

Abstract

Entities:  

Year:  2018        PMID： 29860711     DOI： 10.1007/s00520-018-4302-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  6 in total

1.  Direct comparison of two new actigraphs and polysomnography in children and adolescents.

Authors:  Lisa J Meltzer; Colleen M Walsh; Joel Traylor; Anna M L Westin
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

2.  The role of actigraphy in the assessment of primary insomnia: a retrospective study.

Authors:  Vincenzo Natale; Damien Léger; Monica Martoni; Virginie Bayon; Alex Erbacci
Journal:  Sleep Med       Date:  2013-11-15       Impact factor: 3.492

3.  Methodological challenges when using actigraphy in research.

Authors:  Ann M Berger; Kimberly K Wielgus; Stacey Young-McCaughan; Patricia Fischer; Lynne Farr; Kathryn A Lee
Journal:  J Pain Symptom Manage       Date:  2008-04-08       Impact factor: 3.612

4.  Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study.

Authors:  Sonia Ancoli-Israel; Lianqi Liu; Michelle Rissling; Loki Natarajan; Ariel B Neikrug; Barton W Palmer; Paul J Mills; Barbara A Parker; Georgia Robins Sadler; Jeanne Maglione
Journal:  Support Care Cancer       Date:  2014-04-15       Impact factor: 3.603

Review 5.  Measurements and status of sleep quality in patients with cancers.

Authors:  Dongying Chen; Zongyi Yin; Bo Fang
Journal:  Support Care Cancer       Date:  2017-10-23       Impact factor: 3.603

Review 6.  Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI).

Authors:  Theodore A Omachi
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.